Stock screener

SUPN

Conviction 9HealthcareScan · Thu, Sep 24, 2026

Supernus Pharmaceuticals, Inc. (SUPN) closed at $43.31 (-0.20%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 48, RS Rating 32, -24.0% from its 52-week high, -12.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

SUPN$43.31-0.20%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 663.33K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
SUPERNUS PHARMACEUTICALS, INC.PHARMACEUTICAL PREPARATIONSwww.supernus.com ↗
Price43.31
Change-0.20%
Gap+0.85%
Rel volume1.10×
Avg volume618.46K
Avg $ vol26.42M
SMA 2042.88
SMA 5045.26
SMA 20048.31
Price vs 50-4.33%
Price vs 200-10.36%
MA stackbearish
50/200 cross—
Supertrenddown · 45.09
RSI (14)48
MACD hist0.28
MACD crossbull · 3d
Stoch %K / %D71 / 71
ADX (14)21
+DI / −DI20 / 20
RSI divergence—
MACD divergenceBullish
ATR %3.18%
ADR %2.92%
52w high57.00
52w low41.28
From 52w high-24.03%
Above 52w low+4.91%
New 52w highNo
SqueezeOff
Bollinger width9.43%
%B0.61
Donchian pos61.63%
Donchian high45.05
Donchian low40.51
AVWAP (52w high)47.84
vs AVWAP high-9.48%
AVWAP (52w low)42.45
vs AVWAP low+2.01%
OBV trendDown
Chaikin MF (20)-0.15
Today vs 20d1.10×
Avg vol (14d)663.33K
Avg vol (20d)618.46K
Avg $ vol (20d)26.42M
Market cap2.52B
RS Rating32 / 99
RS 3m (vs SPY)-7.72%
RS 6m (vs SPY)-30.31%
RS line new highNo
Trend template1/8
Technical rank32.5
1 week+0.90%
1 month-4.53%
3 months-3.23%
6 months-13.49%
1 year-7.53%
YTD-12.46%
P/E-65.30
P/B2.44
P/S3.50
P/FCF54.73
EPS-0.6800
Div yield—
ROE-3.74%
ROA-2.70%
Debt/Eq0.39
Current2.08
EV/EBITDA93.53
Gross margin—
Net margin-5.36%
Rev growth8.63%
EPS growth-152.19%
Price target65.20
Target upside50.56%
Analyst ratingBuy
Institutional114.00%
Ent. value2.74B
Revenue219.06M
Net income-58.37M
Gross profit—
Free cash flow45.99M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees778
ListedTue, May 1, 2012
Free float55.36M
Float %95.4%
Short interest4.67M
Days to cover8.3d
Short volume58.3%
Squeeze score56 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.39 vs $0.30
Last surprise+30.0% beat
Setup gradeD
Conviction9 / 100
Pattern quality—
Tech rank32.5 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance51.16
Support40.81
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SUPN · 1 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-03-24
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in SUPN

InsiderSideShares
Bhatt Padmanabh P.
Sr. VP of IP, CSO · Common Stock · 2026-08-12
Exercise2.5K
Bhatt Padmanabh P.
Sr. VP of IP, CSO · Common Stock · 2026-08-12
Tax1.16K
Bhatt Padmanabh P.
Sr. VP of IP, CSO · Performance Share Unit · 2026-08-12
Exercise2.5K
DEC TIMOTHY C
Senior Vice-President & CFO · Common Stock · 2026-08-12
Exercise1.25K
DEC TIMOTHY C
Senior Vice-President & CFO · Common Stock · 2026-08-12
Tax604
DEC TIMOTHY C
Senior Vice-President & CFO · Performance Share Unit · 2026-08-12
Exercise1.25K
Khattar Jack A.
President, CEO · Common Stock · 2026-08-12
Exercise29.85K
Khattar Jack A.
President, CEO · Common Stock · 2026-08-12
Tax12.64K
Khattar Jack A.
President, CEO · Performance Share Unit · 2026-08-12
Exercise29.85K
Mottola Frank
SVP, Chief Tech. Ops. Officer · Common Stock · 2026-08-12
Exercise1.65K

SEC filings

EDGAR filings in SUPN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.